azomycin has been researched along with 4-(3-(2-nitro-1-imidazolyl)-propylamino)-7-chloroquinoline hydrochloride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloomer, WD; Ji, M; Papadopoulou, MV; Rao, MK | 1 |
| Bloomer, WD; McNeil, MR; Papadopoulou, MV | 1 |
| Ali, M; Babur, M; Bloomer, WD; Cawthorne, C; Julyan, PJ; Lunt, SJ; Papadopoulou, MV; Price, PM; Smigova, A; Stratford, IJ; Telfer, BA; Williams, KJ | 1 |
3 other study(ies) available for azomycin and 4-(3-(2-nitro-1-imidazolyl)-propylamino)-7-chloroquinoline hydrochloride
| Article | Year |
|---|---|
Reductive metabolism of the nitroimidazole-based hypoxia-selective cytotoxin NLCQ-1 (NSC 709257).
Topics: Adenosine Monophosphate; Animals; Chromatography, High Pressure Liquid; Cytotoxins; Enzyme Inhibitors; Humans; Imidazoles; Microsomes, Liver; NAD; NAD(P)H Dehydrogenase (Quinone); NADP; Nitroimidazoles; Oxidation-Reduction; Oxygen; Quinolines; Rats | 2003 |
NLCQ-1 and NLCQ-2, two new agents with activity against dormant Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Imidazoles; Inhibitory Concentration 50; Mycobacterium tuberculosis; Nitroimidazoles; Prodrugs; Quinolines; Time Factors; Vero Cells | 2007 |
The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cell Line, Tumor; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation, Preclinical; Imidazoles; Lung Neoplasms; Mice; Mice, Inbred C3H; Neoplasm Metastasis; Nitroimidazoles; Quinolines; Sarcoma; Tirapazamine; Triazines | 2010 |